Proteome Sciences PLC - Asset Resilience Ratio

Latest as of December 2005: 19.84%

Proteome Sciences PLC (PRM) has an Asset Resilience Ratio of 19.84% as of December 2005. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check how strategically is Proteome Sciences PLC's equity deployed to assess the company's strategic physical and investment asset allocation.

Liquid Assets

GBX1.90 Million

≈ $231.18 USD Cash + Short-term Investments

Total Assets

GBX9.58 Million

≈ $1.17K USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2001–2005)

This chart shows how Proteome Sciences PLC's Asset Resilience Ratio has changed over time. See PRM equity financing ratio to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Proteome Sciences PLC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see PRM stock market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	GBX0.00	0%
Short-term Investments	GBX1.90 Million	19.84%
Total Liquid Assets	GBX1.90 Million	19.84%

Asset Resilience Insights

Good Liquidity Position: Proteome Sciences PLC maintains a healthy 19.84% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

Proteome Sciences PLC Industry Peers by Asset Resilience Ratio

Compare Proteome Sciences PLC's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Fleury S.A. SA:FLRY3	Diagnostics & Research	16.06%
Wuhan Thalys Med Tech Co Ltd SHG:603716	Diagnostics & Research	0.12%
Spectral Med Inc TO:EDT	Diagnostics & Research	11.67%
Bcal Diagnostics Ltd AU:BDX	Diagnostics & Research	0.00%
Genetic Signatures Ltd AU:GSS	Diagnostics & Research	60.91%
Sonic Healthcare Ltd AU:SHL	Diagnostics & Research	0.13%
Australian Clinical Labs Ltd AU:ACL	Diagnostics & Research	4.11%
Monash Ivf Group Ltd AU:MVF	Diagnostics & Research	1.60%

Annual Asset Resilience Ratio for Proteome Sciences PLC (2001–2005)

The table below shows the annual Asset Resilience Ratio data for Proteome Sciences PLC.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2005-12-31	19.84%	GBX1.90 Million ≈ $231.18	GBX9.57 Million ≈ $1.17K	+2.44pp
2004-12-31	17.40%	GBX1.80 Million ≈ $219.01	GBX10.34 Million ≈ $1.26K	-15.83pp
2003-12-31	33.24%	GBX4.79 Million ≈ $583.41	GBX14.43 Million ≈ $1.76K	+9.01pp
2002-12-31	24.23%	GBX3.35 Million ≈ $407.51	GBX13.83 Million ≈ $1.68K	+18.22pp
2001-12-31	6.00%	GBX225.00K ≈ $27.38	GBX3.75 Million ≈ $455.90	--

pp = percentage points

About Proteome Sciences PLC

LSE:PRM UK Diagnostics & Research

Market Cap

$68.28K

GBX561.16 Million GBX

Market Cap Rank

#31372 Global

#1175 in UK

Share Price

GBX1.60

Change (1 day)

+0.00%

52-Week Range

GBX1.28 - GBX3.60

All Time High

GBX22.25